Again, I concur. We are in the same position. I personally and our organization here in Canada have not engaged in these conversations and very much confirm that the issue in our perspective is not intellectual property but distribution.
President , AstraZeneca Canada
Again, I concur. We are in the same position. I personally and our organization here in Canada have not engaged in these conversations and very much confirm that the issue in our perspective is not intellectual property but distribution.
See context to find out what was said next.